hrcak mascot   Srce   HID

Stručni rad

Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.

Eftychia Platsidaki ; MD
Evgenia Balamoti ; MD
Anargyros Kouris ; PhD
Alexandra Katsarou ; MD
Nikolaos Mylonakis ; MD
Charitomeni Vavouli ; MD
Georgios Kontochristopoulos ; PhD

Puni tekst: engleski, PDF (124 KB) str. 245-245 preuzimanja: 276* citiraj
APA 6th Edition
Platsidaki, E., Balamoti, E., Kouris, A., Katsarou, A., Mylonakis, N., Vavouli, C. i Kontochristopoulos, G. (2017). Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.. Acta Dermatovenerologica Croatica, 25 (3), 245-245. Preuzeto s https://hrcak.srce.hr/187822
MLA 8th Edition
Platsidaki, Eftychia, et al. "Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.." Acta Dermatovenerologica Croatica, vol. 25, br. 3, 2017, str. 245-245. https://hrcak.srce.hr/187822. Citirano 16.10.2021.
Chicago 17th Edition
Platsidaki, Eftychia, Evgenia Balamoti, Anargyros Kouris, Alexandra Katsarou, Nikolaos Mylonakis, Charitomeni Vavouli i Georgios Kontochristopoulos. "Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.." Acta Dermatovenerologica Croatica 25, br. 3 (2017): 245-245. https://hrcak.srce.hr/187822
Harvard
Platsidaki, E., et al. (2017). 'Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.', Acta Dermatovenerologica Croatica, 25(3), str. 245-245. Preuzeto s: https://hrcak.srce.hr/187822 (Datum pristupa: 16.10.2021.)
Vancouver
Platsidaki E, Balamoti E, Kouris A, Katsarou A, Mylonakis N, Vavouli C i sur. Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.. Acta Dermatovenerol Croat. [Internet]. 2017 [pristupljeno 16.10.2021.];25(3):245-245. Dostupno na: https://hrcak.srce.hr/187822
IEEE
E. Platsidaki, et al., "Bevacizumab-associated sudden onset of multiple monomorphic comedones on the scalp successfully treated with 30% salicylic acid peels.", Acta Dermatovenerologica Croatica, vol.25, br. 3, str. 245-245, 2017. [Online]. Dostupno na: https://hrcak.srce.hr/187822. [Citirano: 16.10.2021.]

Sažetak

Bevacizumab is a humanized monoclonal antibody against vascular endothelial factor (VEGF) that targets tumor cell angiogenesis and proliferation. Although it is usually well tolerated, many side-effects have been reported. These include hypertension, bleeding, and thromboembolic events among others. Drug-associated cutaneous adverse effects are less common and include itching, exfoliative dermatitis, and acneiform eruptions. A man with bevacizumab-associated monomorphic skin eruption successfully was treated with 30% salicylic acid peels. To the author’s knowledge, this is the first report of open comedones with no further inflammatory acne lesions that developed in a patient treated with bevacizumab. Complete remission of the rash was achieved after performing 30% salicylic peels, and the patient continued the chemotherapy as planned with no need of either dose reduction or discontinuation of bevacizumab.

 

Hrčak ID: 187822

URI
https://hrcak.srce.hr/187822

Posjeta: 425 *